Institution
Federal University of Mato Grosso do Sul
Education•Campo Grande, Brazil•
About: Federal University of Mato Grosso do Sul is a education organization based out in Campo Grande, Brazil. It is known for research contribution in the topics: Population & Species richness. The organization has 6903 authors who have published 9030 publications receiving 78977 citations. The organization is also known as: UFMS & Federal University of Mato Grosso do Sul.
Papers published on a yearly basis
Papers
More filters
••
University of the Sciences1, National Institute of Technology, Tiruchirappalli2, Madurai Kamaraj University3, Arizona State University4, Aalto University5, Norwegian University of Science and Technology6, Federal University of Mato Grosso do Sul7, University of Tartu8, Fuel Cells and Hydrogen9, Institute of Company Secretaries of India10, University of Seville11
TL;DR: In this article, the transition from hydrocarbon to H2 economy using fuel cells and H2 technologies is a sustainable and favorable approach forward in meeting stationary, transportation, industrial, residential, and commercial sectors.
161 citations
••
TL;DR: Clinical and epidemiological features of 422 cases of paracoccidioidomycosis attended at University Hospital of Universidade Federal de Mato Grosso do Sul (Campo Grande), Brazil from January 1980 to August 1999, were analysed.
Abstract: Clinical and epidemiological features of 422 cases of paracoccidioidomycosis attended at University Hospital of Universidade Federal de Mato Grosso do Sul (Campo Grande, Mato Grosso do Sul, Brazil) from January 1980 to August 1999, were analysed. The mean age was 43.4 years old and the male: female ratio was 10:1. Nearly half (45.5%) of the patients were agricultural workers at the moment of diagnosis. In the acute/subacute form (juvenile type) the phagocytic-monocytic system was very much impaired and mainly marked by lymphadenopathy (95.4%), hepatomegaly (40%), splenomegaly (23.1%). The chronic form (adult type) presents more lesions in oropharynx (66.4%), dysphonia (31.4%) and cough (50.7%). Mycological diagnosis was obtained by direct microscopy of wet mounts in 185/365 (50.7%) patients and by histopathological examination of biopsies in 294/302 (97.3%) patients. The treatment of choice was Sulfamethoxazole/ trimethoprim (Co-trimoxazole), used in 90.3% patients. Sequelae occurred in 30.3% and death in 7.6% of the cases.
160 citations
••
Finnish Environment Institute1, Universidade Federal de Goiás2, Swiss Federal Institute of Aquatic Science and Technology3, University of Zurich4, University of Tabuk5, Universiti Sains Malaysia6, Swedish University of Agricultural Sciences7, University of Barcelona8, National Scientific and Technical Research Council9, Universidade Federal de Minas Gerais10, University of Guelph11, Institut de recherche pour le développement12, Pontificia Universidad Católica del Ecuador13, University of Hong Kong14, Universidad San Francisco de Quito15, Aarhus University16, National Institute of Amazonian Research17, University of Copenhagen18, Federal University of Mato Grosso do Sul19, University of Basel20, Hungarian Academy of Sciences21, Stellenbosch University22, Sao Paulo State University23, University of Canberra24, University of Otago25
TL;DR: The hypotheses that beta diversity should increase with decreasing latitude and increase with spatial extent of a region have rarely been tested based on a comparative analysis of multiple datasets, and no such study has focused on stream insects.
Abstract: The hypotheses that beta diversity should increase with decreasing latitude and increase with spatial extent of a region have rarely been tested based on a comparative analysis of multiple datasets, and no such study has focused on stream insects. We first assessed how well variability in beta diversity of stream insect metacommunities is predicted by insect group, latitude, spatial extent, altitudinal range, and dataset properties across multiple drainage basins throughout the world. Second, we assessed the relative roles of environmental and spatial factors in driving variation in assemblage composition within each drainage basin. Our analyses were based on a dataset of 95 stream insect metacommunities from 31 drainage basins distributed around the world. We used dissimilarity-based indices to quantify beta diversity for each metacommunity and, subsequently, regressed beta diversity on insect group, latitude, spatial extent, altitudinal range, and dataset properties (e.g., number of sites and percentage of presences). Within each metacommunity, we used a combination of spatial eigenfunction analyses and partial redundancy analysis to partition variation in assemblage structure into environmental, shared, spatial, and unexplained fractions. We found that dataset properties were more important predictors of beta diversity than ecological and geographical factors across multiple drainage basins. In the within-basin analyses, environmental and spatial variables were generally poor predictors of variation in assemblage composition. Our results revealed deviation from general biodiversity patterns because beta diversity did not show the expected decreasing trend with latitude. Our results also call for reconsideration of just how predictable stream assemblages are along ecological gradients, with implications for environmental assessment and conservation decisions. Our findings may also be applicable to other dynamic systems where predictability is low.
160 citations
••
TL;DR: In this paper, the authors summarized nutritional guidelines to support dietary counseling provided by dietitians and health-related professionals, and highlighted the importance of minerals and vitamins such as zinc and vitamins to maintain a well-functioning immune system.
Abstract: Optimal nutrition can improve well-being and might mitigate the risk and morbidity associated with coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This review summarizes nutritional guidelines to support dietary counseling provided by dietitians and health-related professionals. The majority of documents encouraged the consumption of fruits, vegetables, and whole grain foods. Thirty-one percent of the guidelines highlighted the importance of minerals and vitamins such as zinc and vitamins C, A, and D to maintain a well-functioning immune system. Dietary supplementation has not been linked to COVID-19 prevention. However, supplementation with vitamins C and D, as well as with zinc and selenium, was highlighted as potentially beneficial for individuals with, or at risk of, respiratory viral infections or for those in whom nutrient deficiency is detected. There was no convincing evidence that food or food packaging is associated with the transmission of COVID-19, but good hygiene practices for handling and preparing foods were recommended. No changes to breastfeeding recommendations have been made, even in women diagnosed with COVID-19.
159 citations
••
Instituto Butantan1, Federal University of Paraná2, Pontifícia Universidade Católica do Rio Grande do Sul3, University of Brasília4, Universidade Municipal de São Caetano do Sul5, State University of Campinas6, University of São Paulo7, Universidade Federal de Pelotas8, Universidade Federal de Mato Grosso9, Federal University of Mato Grosso do Sul10, National Institutes of Health11, Sinovac Biotech12, Universidade Federal de Minas Gerais13, Faculdade de Medicina de São José do Rio Preto14
TL;DR: A phase 3 clinical trial conducted in healthcare professionals in Brazil demonstrated that the inactivated CoronaVac vaccine has a good safety profile and is efficacious against any symptomatic SARS-CoV-2 infections and highly protective against moderate and severe COVID-19.
Abstract: Background: Vaccines are urgently needed to tackle the unprecedented morbidity and mortality of COVID-19. Administration of inactivated viruses are the common and mature platform of developing new vaccines. CoronaVac is an inactivated vaccine that has undergone preclinical tests and phase I/II clinical trials.
Methods: We conducted a randomised, double-blind, placebo-controlled phase 3 clinical trial with CoronaVac among healthy healthcare professionals in 16 centres in Brazil. Participants received two doses of vaccine (3 μg in 0.5 mL) vaccine or placebo at day 0 and 14. The primary efficacy endpoint was the number of symptomatic COVID-19 cases confirmed by RT-PCR 14 days after the second dose of the vaccine. Prevention of disease severity was a major secondary efficacy endpoint, and adverse events incidence up to seven days after immunization was the primary safety outcome. The trial was registered at ClinicalTrials.gov, NCT04456595.
Findings: Between July 21 and Dec 16, 2020, 12 396 participants were enrolled and received at least one vaccine or placebo dose. There were 9,823 participants who received the two doses and were followed for at least 14 days and had, therefore, reached the final efficacy analysis. There were 253 confirmed COVID-19 cases in the cohort: 85 cases (11.0/100 person-year) among 4,953 participants in the vaccine group, and 168 cases (22·3/100 person-year) among 4,870 participants in the placebo group. The primary efficacy against symptomatic COVID-19 was 50·7% (95%CI 36·0-62·0). The secondary efficacy against cases requiring assistance (score ≥3) and moderate and severe cases (score ≥4) were 83·7% (95%CI 58·0-93.7) and 100% (95%CI 56·4-100.0) respectively. All 6 cases of severe COVID-19 occurred in the placebo group. The incidence of adverse reactions, which was mainly pain at the administration site, was higher in the vaccine group (77·1%) than in the placebo group (66·4%). There were 67 serious adverse events reported by 64 participants and all were determined to be unrelated to vaccination, including two fatal cases. In a subset of participants, neutralizing antibody assays showed similar seroconversion and geometric mean titres against B.1.128, P.1, and P.2 variants.
Interpretation: A phase 3 clinical trial conducted in healthcare professionals in Brazil demonstrated that the inactivated CoronaVac vaccine has a good safety profile and is efficacious against any symptomatic SARS-CoV-2 infections and highly protective against moderate and severe COVID-19.
152 citations
Authors
Showing all 6969 results
Name | H-index | Papers | Citations |
---|---|---|---|
William J. Sutherland | 148 | 966 | 94423 |
Octavio L. Franco | 58 | 463 | 11755 |
Toby A. Gardner | 56 | 141 | 15640 |
Younes Messaddeq | 55 | 621 | 12792 |
Carlos Eduardo Pereira | 54 | 951 | 14155 |
Jens Stoye | 48 | 215 | 8620 |
André Aptroot | 47 | 468 | 13418 |
Carlos Roberto Padovani | 44 | 740 | 9186 |
Wagner Vilegas | 43 | 393 | 7836 |
Edson Marchiori | 42 | 915 | 8416 |
Frank H. Quina | 41 | 205 | 6808 |
Burak Ozpineci | 38 | 165 | 6572 |
Marcos H. Toyama | 36 | 175 | 4087 |
Sérgio de Albuquerque | 36 | 145 | 3342 |
Mário Sérgio Mantovani | 33 | 149 | 3806 |